Summary
Abbott Laboratories (ABT) announced the upcoming retirement of its Executive Vice President, Finance, Robert E. Funck, Jr., effective July 1, 2024. Mr. Funck's departure follows a distinguished 36-year career with the company. This transition marks the end of an era for a key financial executive, and investors will be keen to understand the succession plan and the impact on the company's financial leadership and strategy moving forward.
Key Highlights
- 1Retirement of Robert E. Funck, Jr., Executive Vice President, Finance, effective July 1, 2024.
- 2Mr. Funck has served Abbott Laboratories for 36 years.
- 3The event date for this change was April 25, 2024.
- 4The filing was made on April 30, 2024, with an event date of April 26, 2024 for the officer notification.
- 5This filing falls under Item 5.02 of Form 8-K, concerning director and officer changes.
- 6Philip P. Boudreau, Senior Vice President, Finance and Chief Financial Officer, signed the filing.
Frequently Asked Questions
Robert E. Funck, Jr., Executive Vice President, Finance, is retiring from Abbott Laboratories.
His retirement is effective July 1, 2024.
Mr. Funck has served the company for 36 years.
This announcement signifies a change in key financial leadership. Investors will likely be looking for information regarding the succession plan for Mr. Funck's role and any potential impact on the company's financial strategy and execution.